| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/29/2007 | CN100333794C Adjuvanted genetic vaccines |
| 08/29/2007 | CN100333792C Rsv基因表达疫苗 Rsv gene expression vaccine |
| 08/28/2007 | US7262291 Clostridial toxin derivatives and methods for treating pain |
| 08/28/2007 | US7262289 KCNQ potassium channels and methods of modulating same |
| 08/28/2007 | US7262267 Polypeptide mediating cell permeability |
| 08/28/2007 | US7262175 Anticancer agents; blood disorders |
| 08/28/2007 | US7262174 Causing increased telomerase activity in cells at the wound site |
| 08/28/2007 | US7262173 Chemosensitizing with liposomes containing oligonucleotides |
| 08/28/2007 | US7262167 Treating tumors and other conditions in a patient is provided. The method involves administering to the patient a treatment medicament. The medicament contains a first component and a second component. The first component can be a quantity of |
| 08/28/2007 | US7262052 DNA sequence that encodes a polypeptide that is a voltage activated calcium channel alpha 2 delta -C subunit |
| 08/28/2007 | US7262049 Expression vector for use in the transfer of genetic material in cells |
| 08/28/2007 | US7262044 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 08/28/2007 | US7262033 Cell lines for the propagation of mutated herpes viruses |
| 08/28/2007 | US7262014 Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins |
| 08/28/2007 | US7262012 Providing a first population of single-stranded polynucleotide molecules and a second population of single-stranded polynucleotide molecules, carrying out reaction for digesting, contacting polynucleotide fragments generated from plus strands with fragments generated from the minus strands, amplifying |
| 08/28/2007 | US7261898 Modulating replication via immunogen and pharmaceutically or veterinarily acceptable vehicles |
| 08/28/2007 | US7261897 Fusion proteins of mycobacterium tuberculosis |
| 08/28/2007 | US7261892 Administering an antibody that specifically binds to CD27L for therapy of renal cell carcinoma |
| 08/28/2007 | US7261887 Leishmania as carriers for the delivery of proteins and peptides |
| 08/28/2007 | US7261886 Trichoplusia ni, silkworms, Plutella xylostella in third instar; Autographa californica nucleopolyhedrovirus and Bombyx mori nucleopolyhedrovirus |
| 08/28/2007 | US7261885 Adenoviral vector with replication-dependent transgene expression |
| 08/28/2007 | US7261883 Vaccines containing ribavirin and methods of use thereof |
| 08/28/2007 | US7261882 Delivering antiinflammatory cytokines to nervous system using gene therapy techniques |
| 08/28/2007 | CA2450650C Encapsulated cell therapy |
| 08/28/2007 | CA2177827C Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof |
| 08/24/2007 | CA2568981A1 Integrase-derived hiv-inhibiting agents |
| 08/23/2007 | WO2007095316A2 Compositions and methods for oligonucleotide formulations |
| 08/23/2007 | WO2007095264A1 Method and apparatus for heat or electromagnetic control of gene expression |
| 08/23/2007 | WO2007094755A2 Compositions and methods for modulating cognitive function |
| 08/23/2007 | WO2007094391A1 Method for suppressing gene expression utilizing interdomain interaction |
| 08/23/2007 | WO2007094330A1 Peptide capable of activating bombesin-like peptide receptor and use thereof |
| 08/23/2007 | WO2007094135A1 Oligonucleotide derivative and use thereof |
| 08/23/2007 | WO2007093836A1 Meganuclease variants cleaving a dna target sequence from a xp gene and uses thereof |
| 08/23/2007 | WO2007093042A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 08/23/2007 | WO2007014370A9 Small regulatory rnas and methods of use |
| 08/23/2007 | WO2005107817A3 Medical device with coating for capturing genetically-altered cells and methods of using same |
| 08/23/2007 | WO2005067629A3 Cancer-linked genes as targets for chemotherapy |
| 08/23/2007 | US20070197462 Administering 5-substituted uracil-nucleosides or its pharmaceutically acceptable salt or prodrug for therapy of infected with Epstein-Barr virus (EBV) or Kaposi's sarcoma-associated herpes (KHSV) |
| 08/23/2007 | US20070197460 Rnai inhibition of influenza virus replication |
| 08/23/2007 | US20070197459 Short interfering RNA for use in treatment of cell proliferative disorders |
| 08/23/2007 | US20070197458 Nucleic acid useful for triggering tumor cell lethality |
| 08/23/2007 | US20070197457 Tak1-mediated inhibition of osteogenesis |
| 08/23/2007 | US20070197444 Phage displayed cell binding peptides |
| 08/23/2007 | US20070197443 Methods and Compositions for Modulating Immunity |
| 08/23/2007 | US20070197431 Novel protein for inhibiting tumor progression and increasing nerve regeneration |
| 08/23/2007 | US20070196922 Methods and Compositions Relating to Restricted Expression Lentiviral Vectors and Their Applications |
| 08/23/2007 | US20070196921 Extranuclear RNA splicing in neuronal dendrites |
| 08/23/2007 | US20070196514 Prostate cancer treatment with glycogen synthase kinase-3beta inhibitors |
| 08/23/2007 | US20070196438 Compositions for the treatment of osteoarthritis and to nourish the synovial fluid |
| 08/23/2007 | US20070196393 Recombinant Neospora antigens and their uses |
| 08/23/2007 | US20070196391 Mucosal boosting following parenteral priming |
| 08/23/2007 | US20070196389 Viral gene products and methods for vaccination to prevent viral associated diseases |
| 08/23/2007 | US20070196379 Methods for treating congestive heart failure |
| 08/23/2007 | US20070196378 Hyphae-Specific Cell Wall Proteins Of Candida |
| 08/23/2007 | US20070196377 polynucleotide; rho genes rho proteins; guanosine triphosphate binding proteins; antibody against the protein encodes polynucleotide; detection and treating stomach tumor; determining a disease, a pharmaceutical composition, and a reagent kit |
| 08/23/2007 | US20070196372 Diagnostics and therapeutics for diseases associated with kallikrein 8 (klk8) |
| 08/23/2007 | US20070196370 Type 2 cytokine receptor and nucleic acids encoding same |
| 08/23/2007 | US20070196362 Computational methods and systems to bolster an immune response |
| 08/23/2007 | US20070196346 Poxvirus Vector Encoding Prostate Specific Antigens For Treatment Of Prostate Cancer |
| 08/23/2007 | US20070196343 Fibroblast growth factors; endothelial growth factors; assessing efficiency via monitoring levels of creatine phosphokinase-myocardial band (CPK-MB) isoenzymes; acute coronary artery disease; cardiomyopathy; gene therapy |
| 08/23/2007 | US20070196339 Modified hpv e6 and e7 genes and proteins useful for vaccination |
| 08/23/2007 | US20070196338 Heparin and heparan sulfate binding chimeric vectors |
| 08/23/2007 | US20070196337 Recombinant perforin, expression and uses thereof |
| 08/23/2007 | US20070196336 Method For Constructing Recombinant Herpes Simplex Virus |
| 08/23/2007 | US20070196335 Immune Modulation By Regulating Expression Of The "Minor" Gene In Immune Dendritic Cells |
| 08/23/2007 | US20070196334 Modified vectors for organelle transfection |
| 08/23/2007 | US20070196284 Micelles associated to outer surface of liposome envelope by electrostatic interaction; active compound incorporated into the micelles linking a large amount of active compound to a single liposome carrier; bioavailability; image-enhanced contrast agents for imaging (MRI); tissue-targeted therapy |
| 08/23/2007 | US20070196283 Composition for transfection of DNA into the liver |
| 08/23/2007 | CA2641342A1 Long-acting polypeptides and methods of producing and administering same |
| 08/23/2007 | CA2639149A1 Meganuclease variants cleaving a dna target sequence from a xeroderma pigmentosum gene and uses thereof |
| 08/23/2007 | CA2638823A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 08/23/2007 | CA2635430A1 Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs |
| 08/22/2007 | EP1820862A2 Medical preparations for the treatment of alpha-galactosidase a deficiency |
| 08/22/2007 | EP1820854A2 JNK3 modulators and methods of use |
| 08/22/2007 | EP1820853A2 Recombinant influenza viruses for vaccines and gene therapy |
| 08/22/2007 | EP1819364A2 Immunomodulatory compositions, combinations and methods |
| 08/22/2007 | EP1819226A2 Immunostimulatory combinations and methods |
| 08/22/2007 | EP1622638A4 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
| 08/22/2007 | EP1513538A4 Novel methods for the delivery of polynucleotides to cells |
| 08/22/2007 | EP1190040B1 Herpes simplex virus expressing interleukin-12 gene and and its use for treating cancer |
| 08/22/2007 | EP1017846B1 Control of immune responses by modulating activity of glycosyltransferases |
| 08/22/2007 | EP1003531B1 Processes for preparing nucleic acid constructs |
| 08/22/2007 | EP0877555B1 Use of an inhibitor of an immune system costimulation event for the preparation of a medicament inhibiting the immune system destruction of transplanted viable non-embryonic cells |
| 08/22/2007 | EP0794798B1 Compositions of nucleic acid and viscosity-increasing polymer pvp for use in gene therapy |
| 08/22/2007 | EP0773950B1 Linked peptide nucleic acids |
| 08/22/2007 | CN1332978C Peptide as antagonist of VEGF receptor Flt-1 |
| 08/22/2007 | CN101023177A Non-integrative and non-replicative lentivirus, preparation and uses thereof |
| 08/22/2007 | CN101020065A Regulating function of MR-1 gene in myocardial hypertrophy |
| 08/22/2007 | CN101020064A Brucellosis nucleic acid vaccine |
| 08/22/2007 | CN101020063A Vaccine for preventing and/or treating autoimmune disease |
| 08/22/2007 | CN101020055A SARS vaccine based on replicative vaccinia virus vector |
| 08/22/2007 | CN101020052A AIDS vaccine based on replicative vaccinia virus vector |
| 08/22/2007 | CN101020044A Regulating and controlling effect of thymine DNA glycosylase on signal transducing path |
| 08/21/2007 | USRE39789 Tumor therapy |
| 08/21/2007 | USRE39788 Introducing autologous human cells into a human, autologous human cells having been treated in vitro to insert therein a DNA segment encoding a therapeutic protein, autologous human cells expressing in vivo in human a therapeutically effective amount of therapeutic protein |
| 08/21/2007 | US7259247 Against the costimulatory surface molecule, natural or synthetic ligands, agonists or antagonists of the surface molecule. |
| 08/21/2007 | US7259232 Preferred segments of neural thread protein |
| 08/21/2007 | US7259151 AAV virions with decreased immunoreactivity and uses therefor |
| 08/21/2007 | US7259150 Oligonucleotides; nucleic acid; therapy, diagnosis; cardiovascular disorders, atherosclerosis, anticholesterol agents |
| 08/21/2007 | US7259149 Enhancing the transfection efficiency in treating critical limb ischemia of naked plasmid DNA that encodes hepatocyte growth factor and that is operably linked to a promoter by injecting the DNA directly into the ischemic muscle in combination with hyperbaric oxygen therapy |